SCHEMBL9764540

SCHEMBL9764540

CN(C)C(=O)Cc1ccc(CCCCOCCCCCNCc2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 4/20 0.55
BCHE P06276 1/20 0.48
S1PR1 P21453 5/20 0.47
S1PR3 Q99500 3/20 0.47
S1PR2 O95136 1/20 0.47
CNR1 P21554 1/20 0.47
CNR2 P34972 1/20 0.47
S1PR5 Q9H228 1/20 0.46
TRPV1 Q8NER1 2/20 0.46
MAOA P21397 1/20 0.46
KDM4E B2RXH2 2/20 0.45
LTB4R Q15722 1/20 0.45
LTB4R2 Q9NPC1 1/20 0.45
MAPK1 P28482 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
ATM Q13315 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9762676 0.84 SIGMAR1 (0.52) SIGMAR1BCHES1PR1S1PR3S1PR2
Oxalic Acid SCHEMBL31621151 0.84 SIGMAR1 (0.69) SIGMAR1BCHES1PR1MAOAKDM4E
SCHEMBL456614 0.83 SIGMAR1 (0.80) SIGMAR1BCHECNR1CNR2MAOA
Hydrochloric Acid SCHEMBL9257562 0.81 SIGMAR1 (0.77) SIGMAR1BCHECNR1CNR2MAOA
Hydrochloric Acid SCHEMBL9254084 0.81 SIGMAR1 (0.77) SIGMAR1BCHECNR1CNR2MAOA
Bromide SCHEMBL7121198 0.81 SIGMAR1 (0.77) SIGMAR1BCHECNR1CNR2MAOA
Hydrochloric Acid SCHEMBL454214 0.81 SIGMAR1 (0.77) SIGMAR1BCHECNR1CNR2MAOA
SCHEMBL27496896 0.81 SIGMAR1 (0.77) SIGMAR1BCHECNR1CNR2MAOA
SCHEMBL10465008 0.81 SIGMAR1 (0.53) SIGMAR1BCHES1PR1S1PR3S1PR2
SCHEMBL27851927 0.80 SIGMAR1 (0.67) SIGMAR1BCHECNR1CNR2MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5006556-A Dichloroaniline derivatives for the therapy or prophylaxysis of a disease associated with reversible airway obstruction GLAXO GROUP LIMITED (GB) 1991-04-09 US disclosed
US-4943591-A TREATMENT OF ASTHMA AND BRONCHITIS GLAXO GROUP LIMITED (GB) 1990-07-24 US disclosed